Linking Tau PET to Medial Temporal Lobe Subregions with High Resolution MRI

Linking Tau PET to Medial Temporal Lobe Subregions with High Resolution MRI

Brief description of study

The goal of this research is to collect Tau PET imaging in cognitively normal older adults and patients with Mild Cognitive Impairment (MCI) in the NACC study, to determine relationship to clinical, cognitive, and other biomarker data.
Findings from this study will likely provide insight into the mechanisms and distinctions of age-related cognitive decline and that of Alzheimer's disease.
Only those participants enrolled in the NACC cohort  (protocol 068200) who have received a consensus conference designation of Cognitively Normal or MCI, are eligible to participate in this protocol.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    cognitive impairment, alzheimers
  • Age: Between 60 Years - 99 Years
  • Gender: All


Updated on 09 Mar 2024. Study ID: 833864
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center